Taken together these data demonstrate that mechanisms other than point mutation are responsible for the aberrant CSMD1 expression in head and neck squamous cell carcinoma cell lines, and these data suggest potential targets for further investigation in primary tumors. This evidence concerns the gene CSMD1 and head and neck squamous cell carcinoma.